Skiles et al., J. Med. Chem. 1992, 35, pp. 641-662, "Inhibition of Human Leukocyte Elastase (HLE) by N-Substituted Peptidyl Trifluoromethyl Ketones.sup.1 ". |
Skiles et al., J. Med. Chem. 1992, 35, pp. 4795-4808, "Inhibition of Human Leukocyte Elastase by N-Substituted Peptides Containing alpha", alpha-Difluorostatone Residues at P.sub.1. |
Williams et al., publication, "Biologic Characterization of ICI 200,880 and ICI 200,355", Novel Inhibitors of Human Neutrophil Elastase 1,2 Am Rev. Respir. Dis. 1991, 144:875-883. |
Kawase et al., Tetrahedron Letters, vol. 34, No. 5 pp. 859-862, 1993, "Unexpected Product from the Dakin-West Reaction of N-Acylprolines using Trifluoroacetic Anhydride: A Novel Access to 5-Trifluoromethyl-oxazoles". |
Kawase, J. Chem. Soc., Chem. Commun., 1992, pp. 1076-1077, "Unusual Ring Expansion observed during the Dakin-West Reaction of Tetrahydroisoquinoline-1-carboxylic Acids using Trifluoroacetic Anhydride: an Expedient Synthesis of 3-Benzazepine Derivatives bearing a Trifluoromethyl Group". |
Imperiali et al., "Inhibition of Serine Proteases by Peptidyl Flourumethyl Ketones," Biochemistry vol. 25, pp. 3760-3767 month not available (1986). |
Skiles et al., "Inhibition of Human Leukocyte Elastase (HLE) by N-Substituted Peptidyl Trifluoromethyl Ketones," J. of Medicinal Chemistry, vol. 35, No. 4, pp. 641-662 month not available (1992). |
Repine et al., "Renin Inhibitors Containing Esters at the P.sub.2 -Position. Oral Activity in a Derivative of Methyl Aminomalonate," J. Med. Chem. 34, pp. 1935-1943, month not available (1991). |
Ueda et al., "The synthesis of arginylfluoroalkanes, their inhibition of trypsin and blood-coagulation serine proteinases and their anticoagulant activity," Biochem. J. 265, pp. 539-545, (1990). |
Sham, H.L. et al., "Highly potent and specific inhibitors of human renin," FEBS Letters, vol. 220, No. 2, pp. 299-301, Aug. (1987). |
Chemical Abstract Vo. 111, No. 9, Aug. 28, 1989, Lafuma et al. 111:70314q. |
Powers et al, Chemical Abstracts, vol. 108:33954r, month not available 1988, Mechanism-based inhibitors of human leukocyte elastase. |
Steinmeyer et al, Influence of Some Natural and Semisynthetic Agents on Elastase and Cathepsin G from Polymorphonuclear Granulocytes, Arzneim-Forsch/Drug Res. 41(l), Nr. month not available (1991), pp. 77-80. |
McWherter et al, Novel Inhibitors of Human Leukocyte Elastase and Cathepsin G, Sequence Variants of Squash Seet Protease Inhibitor with Altered Protease Selectivity, Biochemistry month not available, 1989, 28, 5708-5713. |
Reilly et al., The Degradation of Human Lung Elastin by Neutrophil Proteinases, Biochimica et Biophysica Acta, 621 month not available (1980) pp. 147-157. |
Nakajima et al, Mapping the Extended Substrate Binding Site of Cathepsin G and Human Luekoocyte Elastase, The Journal of Biological Chemistry vol 254, No. 10, pp. 4027-4032, May 1979. |
Rice et al, Regulation of Proteolysis at the Neutrophil-Substrate Interface by Secretory Leukoprotease Inhibitor, Science, vol. 249, pp. 178-181, Jul. 1990. |
Travis, Structure, Function, and control of Neutrophil Proteinases, Jun. 24, 1988, The American Journal of Medicine, vol. 84 (Suppl 6A) pp. 37-42. |
Powers, J.C., Eleventh American Peptide Syposium, Abstracts, The Salk Institute and U. of CA, San Diego (1989). Internal notes taken at meeting. |
Travis, J. et al., "Potential Problems in Designing Elastase Inhibitors for Therapy," Am Rev Respir Dis, Pulmonary Perspective, vol. 143 pp. 1412-1415 month not available 1991. |
Petrillo, E.W., et al., Chapter 6. Antihypertensive Agents, Section II. Cardiovascular and Pulmonary Agents, Annual Reports in Medicinal Chemistry, 25, month not available 1989, Academic Press, Inc., D.W. Robertson Editor. |
Chemical Abstract vol. 111, No. 21, Nov. 20, 1989, Galzigna et al. 111:190/312. |
Angelastro et al, "An Efficient Synthesis of Novel a-Diketone and A-Keto Ester Derivatives of N-Protected Amino Acids and Peptides" J. Org. Chem. 54, pp. 3913-3916 month not available (1989). |
Angelastro et al, "Inhibition of Human Neurtophil Elastase with Peptidyl Electrophilic Ketones. 2. Orally Active P.sub.G -Val-Pro-Val-Pentafluoroethyl Ketones" Journal of Medicinal Chemistry, 37 month not available (1994). |
Angelastro et al., "Janus Compounds: Dual Inhibitors of Proteinases" Bioorganic & Medicinal Chemistry Letters, vol. 3, No. 4, pp. 525-530 month not available (1993). |
Mehdi, "Synthetic and Naturally Occurring Protease Inhibitors Containing an Electrophilic Carbonyl Group." Bioorganic Chemistry, 21, pp. 249-259 month not available (1993). |
Angelastro et al., "Efficient Preparation of Peptidyl Pentafluoroethyl Ketones" Tetrahedron Letters, vol. 33, No. 23, pp. 3265-3268 month not available (1992). |
Burkhart, et al, "A Novel Method for the Preparation of Peptidyl a-Keto Esters" Tetrahedron Letters, vol. 31, No. 10, pp. 1385-1388 month not available (1990). |
Peet et al, Synthesis of Peptidyl Fuuoromethyl Ketones and Peptidyl .alpha.-Keto Esters as Inhibitors of Procine Pancreatic Elastase, Human Neutrophil Elastase, and Rat and Human Neutrophil Cathepsin G,J. Med Chem, month not available 1990, 33, pp. 394-407. |
Doherty et al, Novel Inhibitors of Polymorphonuclear Neutrophil (PMN) Elastase and Cathepsin G: Evaluation in vitro of their potential for the Treatment of inflammatory connective tissue damage, Int. J. Immunopharmac, vol. 12, No. 7, pp. 787-795, month not available 1990. |
Mehdi et al, The inhibition of human Neutrophil elastase and cathepsin G by Peptidyl 1,2-dicarbonyl derivatives, Biochemical and Biophysical Research Communications, vol. 166, No. 2, Jan. 1990, pp. 595-600. |
Shah et al., Orally Active .beta.-Lactam Inhibitors of Human Leukocyte Elastase-1. J. Med Chem, 35, pp. 3745-3754 month not available (1992). |
Snider, Experimental Studies on Emphysema and Chronic Bronchial Injury, Eur. J. Respir Dis month not available (1986) 69 (Suppl. 146) pp. 17-35. |
Malech et al, Current Concepts: Immunology Neutrophils in Human Diseases, Medical Intelligence-vol. 317. No. 11, Sep. 1987. |
Fletcher et al, A comparison of .alpha..sub.1 -Proteinase Inhibitor Methoxysuccinyl-ala-ala-pro-val-chloromethylketone and Specific .beta.-Lactam Inhibitors in a accute Model of Human Polymorphonuclear Leukocyte Elastase-induced Lung Hemorrhage in the hamster, Am Rev Respir Dis month not available 990; 141:672-677. |
Hassall et al, A new class of inhibitors of human leucocyte elastase, FEBS 2444, vol. 183, No. 2, Apr. 1985. |
Bundgaard, Hans, "Design of Bioreversible Drug Derivatives and the Utility of the Double Prodrug Concept", Bioreversible Carriers In Drug Design, 1987 pp. 13, 63-65. |
Imperiali et al, Biochemistry, vol. 21, pp. 3760-3767 (1986). |
Powers, J.C., Eleventh American Peptide Symposium, Abstracts, The Salk Institute and U. of CA, San Diego (1989). Internal Notes taken at meeting. |
Angelastro et al, Bioorganic & Medicinal Chemistry Letters, vol. 2, No 10, pp. 1235-1238 (1992). |
J. Med. Chem. 33, pp. 11-13 (1990) "Communications to the Editor". |
Copeland, T.D. et al, Biochem. Biophys. Res. Commun,. vol. 169., No. 1, pp. 310-314 (1990). |
P.G. Gassman et al, J. Org. Chem. vol. 52, pp. 2481-2490, (1987). |
Desai, R.C. et al, Bioorg. Med. Chem. Lett. 5, pp. 105-109 (1995). |
Davies, P., et al Ann. N.Y. Acad. Sci. 624, pp. 219-233 (1992). |
Durham et al, J. Pharm. Exp. Ther., vol. 270, No. 1, pp. 185-191 (1994). |
Zhaozhao Li et al, J. Med. Chem, 1993, 36, pp. 3472-3480. |
Isabel Charles et al, J.C.S, Perkin I, 1980, pp. 1139-1146. |
Janusz, M. et al, J. Immunol. (1991), vol. 146, pp. 3922-3928. |
Janusz, M. et al, J. Pharmacol. Exp. Ther., (1995), vol. 275, pp. 1233-1238. |
Burkhart et al, J. Med. Chem., 38, pp. 223-233 (1995). |